Dupixent (Dupilumab) for asthma | MyAsthmaTeam

Connect with others who understand.

sign up Log in
About MyAsthmaTeam
Powered By

Dupixent is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for use in people age 12 and older with moderate to severe asthma that is not adequately controlled with other medications. Dupixent is not a rescue medication for sudden asthma attacks. Dupixent is also known by its drug name, dupilumab.

Dupixent is an immunomodulator, a drug that modulates the immune system. It is considered a biologic. Dupixent is believed to work by blocking the interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling pathways to reduce inflammation.

How do I take it?
Dupixent is administered by subcutaneous injection. Use Dupixent exactly as prescribed by your doctor.

Dupixent is available as a prefilled syringe or a prefilled pen.

Side effects
The FDA-approved label for Dupixent lists common side effects including injection site reactions, pain in the back of the throat, eye inflammation, cold sores, insomnia, toothache, stomach pain, joint pain, face rash, and an increase in certain types of white blood cells.

Rare but serious side effects listed for Dupixent include severe allergic reactions or anaphylaxis, eye pain and vision changes, and blood vessel inflammation characterized by fever, chest pain, rash, shortness of breath, or numbness in the arms and legs.

For more details about this treatment, visit:

Dupixent – Sanofi

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of use and Privacy policy.
Already a Member? Log in